glp-1 drug news today medications could cut US mortality by 6.4%, new study finds GLP-1 drugs now have new

Thus, both GIP and GLP-1 agonists have independently proven themselves to be efficient in protecting the kidneys

Others may struggle with the idea of long-term pharmacologic support for weight management

Numerous individuals have reported unbearable stomach pains, an inability to keep down solid foods, and prolonged vomiting and diarrhea

**The listing of a company (e.g., Novo Nordisk, Eli Lilly) or product (e.g., Ozempic, Mounjaro, Wegovy, Rybelsus, Trulicity, Saxenda or Zepbound) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective

In both trials, major cardiovascular (MACE) events occurred equally in linagliptin-treated patients compared to those receiving other medications